Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other biologically active compounds. The bromo substituent enables cross-coupling reactions, while the hydroxymethyl group supports nucleophilic substitutions and oxidations, allowing further chemical modifications. This makes it valuable in medicinal chemistry for creating drug candidates targeting cancer and inflammatory diseases, as well as building complex heterocyclic systems found in modern therapeutics.